Ray Co

Ray Co Net Margin

The Net Profit Margin of Ray Co (228670.KQ) as of Nov 22, 2026 is 2.82 %. In the previous year, Net Profit Margin was -75.68 % — a change of -103.72% (higher).

Net Margin

2.82 %

YoY

-103.72%

Last updated:

Net Profit Margin of Ray Co is 2025 2.82 % . Net Profit Margin of Ray Co was 2024 -75.68 % . It decreases by -103.72% higher compared to the previous year.

For Ray Co, the net margin of 2.8% is up versus -0.0% a few years ago.

The Ray Co Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2018
10.19 KRW
Jan 1, 2019
15.81 KRW
Jan 1, 2020
14.32 KRW
Jan 1, 2021
-0.01 KRW
Jan 1, 2022
6.17 KRW
Jan 1, 2023
-1.47 KRW
Jan 1, 2024
-75.68 KRW
Jan 1, 2025
2.82 KRW
The Ray Co Net Margin history
YEARNet MarginYoY
2.82 %-103.72%
-75.68 %+5,043.99%
-1.47 %-123.85%
6.17 %-43,752.95%
-0.01 %-100.10%
14.32 %-9.42%
15.81 %+55.11%
10.19 %+190.73%
3.51 %-45.78%
6.46 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ray Co Stock analysis

What does Ray Co do? Ray Co., Ltd. generates revenue through the manufacturing and sale of advanced technology medical devices, focusing on digital diagnostic systems and digital therapy solutions. The company produces dental radiography equipment such as x-ray systems and cone beam computed tomography (CBCT) systems, alongside 3D scanning, dental computer aided design (CAD), and 3D printers for prosthodontics, orthodontics, and implant surgery. Domestic and overseas markets purchase these products, with the company operating through subsidiaries to distribute its offerings globally. Digital diagnostic systems like dental radiography equipment and CBCT systems are sold to healthcare providers and dental clinics, while digital therapy solutions including 3D scanning and CAD systems target dental laboratories and surgical centers. The firm's product portfolio serves both domestic and international clients, leveraging its subsidiaries for global distribution channels. Ray Co., Ltd. emphasizes advanced technology in its medical device offerings, with digital therapy solutions such as 3D printers and CAD systems being key revenue drivers. The company's focus on dental-specific applications ensures targeted sales to specialized healthcare segments, including prosthodontics, orthodontics, and implant surgery practices. Ray Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ray Co stock

Net Profit Margin of Ray Co is 2.82 % in 2025.

Net Profit Margin of Ray Co changed from -75.68 % to 2.82 %, representing a -103.72% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Ray Co since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Ray Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Ray Co

All Key Metrics — Ray Co